SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-214226
Filing Date
2020-08-10
Accepted
2020-08-10 09:07:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d53839d424b5.htm 424B5 368932
2 GRAPHIC g53839g04n66.jpg GRAPHIC 56737
  Complete submission text file 0001193125-20-214226.txt   448417
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238300 | Film No.: 201087395
SIC: 2834 Pharmaceutical Preparations